Skip to main content
Advertisement
Advertisement

CATX

CATX logo

Perspective Therapeutics, Inc.

2.62
USD
Sponsored
-0.34
-11.49%
Sep 23, 16:00 UTC -4
Closed
exchange

After-Market

2.60

-0.02
-0.69%

CATX Earnings Reports

Positive Surprise Ratio

CATX beat 24 of 36 last estimates.

67%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Perspective Therapeutics, Inc. earnings per share and revenue

On Aug 10, 2026, CATX reported earnings of -0.22 USD per share (EPS) for Q2 26, beating the estimate of -0.26 USD, resulting in a 15.87% surprise. Revenue reached 81.00 thousand, compared to an expected 84.81 thousand, with a -4.50% difference. The market reacted with a +6.00% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Perspective Therapeutics, Inc. reported EPS of -$0.22, beating estimates by 15.87%, and revenue of $81.00K, -4.5% below expectations.
The stock price moved up 6%, changed from $3.00 before the earnings release to $3.18 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Perspective Therapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement